Table 2 : Drug therapy, blood glucose, serum creatinine and potassium in a patient with drug-induced hyperglycemia (Patient 3)
Date |
Therapy |
Glucose (mg/dL) |
Scr |
Serum K (mmol/L) |
||||
F |
2-hPP |
F |
2-hPP |
F |
2-hPP |
|||
Dec 2004 |
HCTZ, SlowK, Amiloride, Amlodipine, MgOxide |
104 |
ND |
1.2 |
ND |
3.6 |
ND |
|
Feb 2005 |
Same as before |
117 |
ND |
1.2 |
ND |
3.9 |
ND |
|
Oct 2010 |
Triam+HCTZ (37.5/25) Mon,Wed,Fri |
123 |
ND |
1.3 |
ND |
4.1 |
ND |
|
Sept 8, 2011 |
Triam+HCTZ Mon, Fri |
123 |
207 |
1.3 |
1.47 |
4.2 |
3.4 |
|
She was told by her primary physician that she was developing diabetes. Action: Hold Triam HCTZ, add Aldomet 250 mg TID to control blood pressure, reduce KCl to 20 mEq once daily. |
||||||||
Sept 23, 2011 |
Hold Triam/HCTZ |
114 |
144 |
1.2 |
1.3 |
4.0 |
4.0 |
|
Actions: 1) Triam + HCTZ discontinued, 2) Bemetamide 0.5 mg PO Mon, Wed, Fri, 3) ↑KCl 20 mEq BID |
||||||||
Nov 2011 |
Bumetanide |
108 |
118 |
1.3 |
1.4 |
4.1 |
4.0 |
|
<p >ND = Not Done Scr= Serum Creatinine F = Fasting 2-hPP = 2 hour Postprandial